Clinical Trials Browser

Phase 2 × testosterone undecanoate × Clear all

NCT05081193 2025-09-22

Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT04049331 2025-03-11

Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone

Phase 2 Recruiting

Eunuchism, Hypogonadism, Fatigue Syndrome, Chronic

NCT03379012 2019-10-22

FARETES

Phase 2 Completed

Carcinoma, Renal Cell